Dr. John Boockvar, MD
Claim this profileLenox Hill Brain Tumor Center
Expert in Glioblastoma
Studies Brain Cancer
19 reported clinical trials
29 drugs studied
Area of expertise
1Glioblastoma
Global LeaderStage IV
IDH negative
EGFR positive
2Brain Cancer
EGFR positive
Stage IV
IDH negative
Affiliated Hospitals
Clinical Trials John Boockvar, MD is currently running
Surgical Tissue Flap
for Glioblastoma
This single center, single arm, open-label, phase 2 study will assess the safety and efficacy of a pedicled temporoparietal fascial (TPF) or pericranial flap into the resection cavity of newly diagnosed glioblastoma multifome (GBM) patients. The objective of the Phase 2 study is to demonstrate that this surgical technique is safe and effective in a human cohort of patients with resected newly diagnosed AA or GBM and may improve progression-free survival (PFS) and overall survival (OS).
Recruiting1 award N/A
SIACI Bevacizumab + Temozolomide and Radiation
for Glioblastoma
This trial tests a new treatment for aggressive brain cancer by using Mannitol to open the brain's barrier and then delivering Bevacizumab directly into the brain's arteries. It aims to improve survival rates for patients with newly diagnosed Glioblastoma Multiforme. Bevacizumab, typically administered intravenously, has shown superior outcomes when delivered directly into the brain's arteries in patients with recurrent Glioblastoma Multiforme.
Recruiting2 awards Phase 3
More about John Boockvar, MD
Clinical Trial Related2 years of experience running clinical trials · Led 19 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments John Boockvar, MD has experience with
- Temozolomide
- Bevacizumab
- Cetuximab
- Capecitabine
- Hypofractionated Re-irradiation
- Surgical Tissue Flap
Breakdown of trials John Boockvar, MD has run
Glioblastoma
Brain Cancer
Brain Metastases
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does John Boockvar, MD specialize in?
John Boockvar, MD focuses on Glioblastoma and Brain Cancer. In particular, much of their work with Glioblastoma has involved Stage IV patients, or patients who are IDH negative.
Is John Boockvar, MD currently recruiting for clinical trials?
Yes, John Boockvar, MD is currently recruiting for 8 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that John Boockvar, MD has studied deeply?
Yes, John Boockvar, MD has studied treatments such as Temozolomide, Bevacizumab, Cetuximab.
What is the best way to schedule an appointment with John Boockvar, MD?
Apply for one of the trials that John Boockvar, MD is conducting.
What is the office address of John Boockvar, MD?
The office of John Boockvar, MD is located at: Lenox Hill Brain Tumor Center, New York, New York 10075 United States. This is the address for their practice at the Lenox Hill Brain Tumor Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.